DLD Asset Management’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-3,900
Closed -$701K 128
2017
Q3
$701K Buy
+3,900
New +$543K 0.07% 56

DLD Asset Management's KITE Position: Q4 2017 in Review

DLD Asset Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 3,900 shares — an estimated $701K sold.

DLD Asset Management first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $701K in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • DLD Asset Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • DLD Asset Management sold 3,900 Kite Pharma, Inc. shares in Q4 2017, an estimated $701K.
  • DLD Asset Management first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
  • DLD Asset Management's Kite Pharma, Inc. position peaked at $701K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on DLD Asset Management's 13F filing for Q4 2017, filed 12 Feb 2018.